APA (7th ed.) Citation

MA, C., A, G., M, S., J, L., CC, S., B, F., . . . RD, B. (2018). Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(9), 2194. https://doi.org/10.1158/1078-0432.CCR-17-3251

Chicago Style (17th ed.) Citation

MA, Clarke, et al. "Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency Across 12 Genotypes and Potential Impact on Management of HPV-Positive Women." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 24, no. 9 (2018): 2194. https://doi.org/10.1158/1078-0432.CCR-17-3251.

MLA (9th ed.) Citation

MA, Clarke, et al. "Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency Across 12 Genotypes and Potential Impact on Management of HPV-Positive Women." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 24, no. 9, 2018, p. 2194, https://doi.org/10.1158/1078-0432.CCR-17-3251.